Telix Pharmaceuticals Ltd. - ADR Live Stock Price Today, Share Analysis and Chart

Name: Telix Pharmaceuticals Ltd. - ADR: Is Infosys Ltd. worth buying?
Item: Telix Pharmaceuticals Ltd. - ADR
Rating: 0.79916675
Author: Trendlyne DVM scores

about

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tom...

9.71 -0.17 (-1.72%)

68.02% Fall from 52W High

180.5K

XNAS Volume

XNAS 07 Nov, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

3.7 / 100

Technically Bearish

28.3 / 100

1Yr Price target upside is 114%

4 analysts

Telix Pharmaceuticals ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Telix Pharmaceuticals Ltd. - ADR Live Stock Price Today, Share Analysis and Chart

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tom...

68.02% Fall from 52W High

SWOT Analysis

Telix Pharmaceuticals ADR Live Price Chart